For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Acalabrutinib | All participants who received acalabrutinib | 0 | None | 3 | 10 | 5 | 10 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Sports-related concussion | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Sports-related injury | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Emergency room visit after baseline food challenge | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Elevated liver function tests | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | None | View |
| Leukocytosis | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Hyperglycemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Neutropenia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Anemia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Eosinophilia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| COVID-19 infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Hypokalemia | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Hypoalbuminemia | SYSTEMATIC_ASSESSMENT | General disorders | None | View |